245 related articles for article (PubMed ID: 18240308)
1. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells.
Flaiz C; Utermark T; Parkinson DB; Poetsch A; Hanemann CO
Glia; 2008 Apr; 56(5):506-15. PubMed ID: 18240308
[TBL] [Abstract][Full Text] [Related]
2. Actin-rich protrusions and nonlocalized GTPase activation in Merlin-deficient schwannomas.
Flaiz C; Kaempchen K; Matthies C; Hanemann CO
J Neuropathol Exp Neurol; 2007 Jul; 66(7):608-16. PubMed ID: 17620986
[TBL] [Abstract][Full Text] [Related]
3. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.
Pelton PD; Sherman LS; Rizvi TA; Marchionni MA; Wood P; Friedman RA; Ratner N
Oncogene; 1998 Oct; 17(17):2195-209. PubMed ID: 9811451
[TBL] [Abstract][Full Text] [Related]
4. Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.
Flaiz C; Ammoun S; Biebl A; Hanemann CO
Brain Pathol; 2009 Jan; 19(1):27-38. PubMed ID: 18445079
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase kappa and SHP-1 are involved in the regulation of cell-cell contacts at adherens junctions in the exocrine pancreas.
Schnekenburger J; Mayerle J; Krüger B; Buchwalow I; Weiss FU; Albrecht E; Samoilova VE; Domschke W; Lerch MM
Gut; 2005 Oct; 54(10):1445-55. PubMed ID: 15987791
[TBL] [Abstract][Full Text] [Related]
7. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways.
Zhou L; Ercolano E; Ammoun S; Schmid MC; Barczyk MA; Hanemann CO
Neoplasia; 2011 Dec; 13(12):1101-12. PubMed ID: 22247700
[TBL] [Abstract][Full Text] [Related]
8. Rearrangements of the intermediate filament GFAP in primary human schwannoma cells.
Utermark T; Schubert SJ; Hanemann CO
Neurobiol Dis; 2005; 19(1-2):1-9. PubMed ID: 15837555
[TBL] [Abstract][Full Text] [Related]
9. MEK/ERK regulates adherens junctions and migration through Rac1.
Ray RM; Vaidya RJ; Johnson LR
Cell Motil Cytoskeleton; 2007 Mar; 64(3):143-56. PubMed ID: 17183546
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival.
Ammoun S; Schmid MC; Zhou L; Ristic N; Ercolano E; Hilton DA; Perks CM; Hanemann CO
Oncogene; 2012 Mar; 31(13):1710-22. PubMed ID: 21892205
[TBL] [Abstract][Full Text] [Related]
11. Cdc42 is crucial for the maturation of primordial cell junctions in keratinocytes independent of Rac1.
Du D; Pedersen E; Wang Z; Karlsson R; Chen Z; Wu X; Brakebusch C
Exp Cell Res; 2009 May; 315(8):1480-9. PubMed ID: 19100259
[TBL] [Abstract][Full Text] [Related]
12. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
[TBL] [Abstract][Full Text] [Related]
13. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
[TBL] [Abstract][Full Text] [Related]
14. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression between human schwannoma and control Schwann cells.
Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells.
Kaempchen K; Mielke K; Utermark T; Langmesser S; Hanemann CO
Hum Mol Genet; 2003 Jun; 12(11):1211-21. PubMed ID: 12761036
[TBL] [Abstract][Full Text] [Related]
19. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
[TBL] [Abstract][Full Text] [Related]
20. Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.
Doddrell RD; Dun XP; Shivane A; Feltri ML; Wrabetz L; Wegner M; Sock E; Hanemann CO; Parkinson DB
Brain; 2013 Feb; 136(Pt 2):549-63. PubMed ID: 23413263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
